Hawthorn leaf polyphenols (HLP) possess good biological activity and significant therapeutic potential; however, their application is severely limited by their poor physicochemical stability and low bioavailability.To address the above issues, this study encapsulated HLP using soy protein isolate (SPI) and hydroxypropyl methylcellulose (HPMC), resulting in HLP-NPs with a high encapsulation efficiency of 79.30 ± 0.11%.The resulting nanoparticles exhibited a distinct spherical morphology, with an average hydrodynamic diameter of 98.97 ± 7.48 nm and a zeta potential of −24.82 ± 2.27 mV, indicating good electrostatic repulsion and colloidal stability.In vitro gastrointestinal digestion experiments demonstrated that HLP-NPs significantly improved the bioavailability of HLP, with the nanocapsulation increasing HLP’s bioavailability from 31.19 ± 3.65% to 67.65 ± 4.25%.Stability testing further demonstrated that HLP-NPs exhibit excellent tolerance to various environmental stressors. Respectively, it is worth noting that, Nanoencapsulation significantly enhanced the antioxidant capacity of HLP, with the IC₅₀ values for DPPH and ABTS radical scavenging decreasing from 33.54 ± 1.59 and 93.53 ± 15.76 μg/mL (unencapsulated HLP) to 19.67 ± 1.29 and 13.39 ± 0.54 μg/mL (HLP-NPs).Furthermore, in cellular models, HLP-NPs demonstrated superior anti-inflammatory and hypoglycemic effects compared to free HLP. In summary, HLP can be developed as a nutritional supplement with antioxidant and blood-glucose-lowering properties. Overall, HLP-NPs can be developed as a nutritional supplement with antioxidant and hypoglycemic properties. Furthermore, this study provides valuable insights for the application of other botanically derived polyphenols.